GUGGENHIME ANDREW
SEC insider (Form 3/4/5 filer). CIK 0001230724. PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX) and 1 other issuer. 57 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in SAN CARLOS, CA.
Companies GUGGENHIME ANDREW has filed insider reports for
- Vaxcyte, Inc. (PCVX): Officer, PRESIDENT AND CFO
- Caribou Biosciences, Inc. (CRBU): Director
GUGGENHIME ANDREW
CIK: 0001230724
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)22 (38.6%)
Position reduction
Option Exercises (M)14 (24.6%)
Derivative conversions
Awards (A)6 (10.5%)
Compensation grants
Other (G, F, J, C, D, …)15 (26.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (57 total)
- Sep 8, 2026PCVX
Vaxcyte, Inc.
Tax PaymentDirect7.2K shares at avg. $60.36$432K - Sep 2, 2026PCVX
Vaxcyte, Inc.
Tax PaymentDirect1.4K shares at avg. $61.58$88K - Aug 31, 2026PCVX
Vaxcyte, Inc.
Tax PaymentDirect1.3K shares at avg. $60.74$77K - Aug 3, 2026PCVX
Vaxcyte, Inc.
SaleDirect7K shares at avg. $53.76$374K - Aug 3, 2026PCVX
Vaxcyte, Inc.
ExerciseDirect10K shares at avg. $5.35$54K - Aug 3, 2026PCVX
Vaxcyte, Inc.
SaleDirect3K shares at avg. $54.18$165K - Jul 6, 2026PCVX
Vaxcyte, Inc.
SaleDirect2.1K shares at avg. $57.76$121K - Jul 6, 2026PCVX
Vaxcyte, Inc.
SaleDirect7.9K shares at avg. $57.16$452K - Jul 6, 2026PCVX
Vaxcyte, Inc.
ExerciseDirect10K shares at avg. $5.35$54K - Jun 18, 2026PCVX
Vaxcyte, Inc.
ExerciseDirect10K shares at avg. $5.35$54K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 |  PCVX Vaxcyte, Inc. | Tax Payment | 7,155 | $60.36 | $431,876 | Direct |
| Sep 2, 2026 | PCVX Vaxcyte, Inc. | Tax Payment | 1,432 | $61.58 | $88,183 | Direct |
| Aug 31, 2026 | PCVX Vaxcyte, Inc. | Tax Payment | 1,273 | $60.74 | $77,322 | Direct |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | Sale | 6,956 | $53.76 | $373,962 | Direct |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | Exercise | 10,000 | $5.35 | $53,500 | Direct |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | Sale | 3,044 | $54.18 | $164,918 | Direct |
| Jul 6, 2026 | PCVX Vaxcyte, Inc. | Sale | 2,087 | $57.76 | $120,553 | Direct |
| Jul 6, 2026 | PCVX Vaxcyte, Inc. | Sale | 7,913 | $57.16 | $452,283 | Direct |
| Jul 6, 2026 | PCVX Vaxcyte, Inc. | Exercise | 10,000 | $5.35 | $53,500 | Direct |
| Jun 18, 2026 | PCVX Vaxcyte, Inc. | Exercise | 10,000 | $5.35 | $53,500 | Direct |
1-10 of 57 transactions
…